For the quarter ending 2025-09-30, CLPT has $60,357K in assets. $44,483K in debts. $38,221K in cash and cash equivalents.
| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 38,221 | 41,541 | ||
| Accounts receivable, net | 4,000 | 4,260 | ||
| Inventory, net | 6,583 | 6,293 | ||
| Prepaid expenses and other current assets | 2,525 | 1,897 | ||
| Total current assets | 51,329 | 53,991 | ||
| Property and equipment, net | 2,114 | 2,019 | ||
| Operating lease, right-of-use assets | 5,955 | 6,139 | ||
| Other assets | 959 | 720 | ||
| Total assets | 60,357 | 62,869 | ||
| Accounts payable | 723 | 1,531 | ||
| Accrued compensation | 3,516 | 2,949 | ||
| Other accrued liabilities | 1,748 | 1,210 | ||
| Operating lease liabilities, current portion | 347 | 331 | ||
| Contract liabilities, current portion | 1,719 | 1,377 | ||
| Total current liabilities | 8,053 | 7,398 | ||
| Operating lease liabilities, net of current portion | 6,195 | 6,280 | ||
| Contract liabilities, net of current portion | 769 | 603 | ||
| Long-term note payable, net | 29,203 | 28,845 | ||
| Other long-term liabilities | 263 | - | ||
| Total liabilities | 44,483 | 43,126 | ||
| Common stock, 0.01 par value 90,000,000 shares authorized at september 30, 2025 and december 31, 2024 28,428,176 and 27,617,415 shares issued and outstanding at september 30, 2025 and december 31, 2024, respectively | 284 | 284 | ||
| Additional paid-in capital | 224,714 | 222,692 | ||
| Accumulated deficit | -209,124 | -203,233 | ||
| Total stockholders equity | 15,874 | 19,743 | ||
| Total liabilities and stockholders equity | 60,357 | 62,869 | ||
ClearPoint Neuro, Inc. (CLPT)
ClearPoint Neuro, Inc. (CLPT)